Просмотр новости

Найдите то, что Вас интересует

Semaglutide may reduce fracture risk in type 2 diabetes

Дата публикации: 24-06-2026 12:50:37

CHICAGO — Adults with type 2 diabetes may have lower risk for fractures if they use semaglutide compared with other medications, according to data presented at ENDO 2026.As Healio previously reported, a retrospective cohort study found that semaglutide (Ozempic/Wegovy, Novo Nordisk) was associated with a 26% lower risk for fractures than sleeve gastrectomy for people with obesity. Sun H. Kim, MS, MD, associate professor of medicine at Stanford University Medical Center and senior author on the previous study, said researchers thought the reduced risk for fracture with semaglutide may have

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Ozempic tied to improved quality of life in type 2 diabetes, CKD0012-06-2026
2Can Ozempic lessen the risk of broken bones?0022-06-2026
3Foundayo bests Farxiga and Ozempic pill in type 2 diabetes trials0819-06-2026
4Novel oral GLP-1 confers glucose, weight reduction5723-06-2026
5GLP-1s linked to elevated rates of hypotensive events0013-06-2026
6Sleep Apnea May Amplify GLP-1 Survival Benefits in Type 2 Diabetes0023-10-2025
7GLP-1 RAs do not improve migraines0619-06-2026
8Stanford researchers say your body already makes this Ozempic alternative0715-06-2026
9Dr. Santina Wheat with the latest developments on GLP-1s0021-06-2026
10В России бум похудения на уколах – врачи в шоке и бьют тревогу-2624-06-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5. Источник: www.healio.com.